| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6818886 | Psychoneuroendocrinology | 2015 | 7 Pages |
Abstract
No clinically relevant cognitive impairment was found in patients with AI compared to matched controls. Even long-term glucocorticoid and mineralocorticoid substitution over almost two decades appears to have only subtle effects on cognition in patients with AI.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Katharina Schultebraucks, Katja Wingenfeld, Jana Heimes, Marcus Quinkler, Christian Otte,